Israel’s benchmark TA-25 index dropped for a fifth time in six days, retreating 0.2 percent to 1,057.42 at the 4:30 p.m. close in Tel Aviv. Investors traded about 737 million shekels ($184 million) of shares and convertible securities, according to bourse data.
The following stocks rose or fell. Symbols are in parentheses.
EZchip Semiconductor Ltd. (EZCH) dropped 3.1 percent, the most since July 15, to 129.7 shekels, or the equivalent of $32.30. The New York-traded shares of the Israeli developer of network processors dropped 2.7 percent at $32.48 yesterday.
Magic Software Enterprises Ltd. (MGIC:US) slid 4.8 percent to 19.15 shekels, or the equivalent of $4.77, the lowest since Nov. 27. The technology company’s U.S.-traded shares fell 6.1 percent to $4.80 yesterday.
Mellanox Technologies Ltd. (MLNX:US) declined 4 percent to 253.5 shekels, or the equivalent of $63.13, the lowest level since June 14. The New York-traded stock of the Israeli developer of technology used to transfer and store data, dropped 5.5 percent to $62.24 yesterday.
Pluristem Therapeutics Inc. (PSTI) advanced 4 percent, the most since July 3, to 9.88 shekels. The developer of stem- cell therapies said it partnered with CPC Clinical Research on an peripheral artery disease Phase II study.
Ratio Oil Exploration 1992 LP (RATIL) rose as much as 6.3 percent and closed 1.7 percent higher at 0.242 shekel. Globes business daily reported a deal for a well in Mozambique signifies a higher value for the Leviathan well in which the oil and gas exploration company is a partner. Avner Oil Exploration LLP (AVNRL) and Delek Drilling-LP (DEDRL) , also partners in the Leviathan field, advanced 1.6 percent and 1.9 percent, respectively.
Teva Pharmaceutical Industries Ltd. (TEVA) gained 1.9 percent to 168.2 shekels, or the equivalent of $41.88. The U.S.- traded shares of the world’s largest generic drugmaker rose 2.9 percent to $42.34 yesterday.
To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at email@example.com
To contact the editor responsible for this story: Claudia Maedler at firstname.lastname@example.org